Toll-like receptor 4 — Drug Target

2 drugs 1 in Phase 3

All drugs that target Toll-like receptor 4 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Phase 3 pipeline (1)

ERITORAN · Immunology
ERITORAN works by binding to Toll-like receptor 4, a protein involved in the immune response.

Phase 2 pipeline (1)

GSK Biologicals' AS01B adjuvant · GlaxoSmithKline · Adjuvant · Vaccines
Stimulates Toll-like receptor 4 and MyD88-dependent signaling pathway